Belsar-M 5 mg+40 mg (Tablet)
Unit Price: ৳ 20.00 (4 x 7: ৳ 560.00)
Strip Price: ৳ 140.00
Medicine Details
Category | Details |
---|---|
Generic | Amlodipine besilate olmesartan medoxomil |
Company | Beacon pharmaceuticals plc |
Also available as |
Title and Categories
- Belsar-M Combination Drug
- Antihypertensive
- Calcium Channel Blocker
- Angiotensin II Receptor Antagonist
- Hypertension Treatment
Indications
- Treatment of hypertension
- Lowering blood pressure
- Initial therapy for patients likely to need multiple antihypertensive agents
Pharmacology
- Amlodipine as dihydropyridine calcium channel blocker
- Greater effect on vascular smooth muscle cells
- Peripheral arterial vasodilator
- Olmesartan Medoxomil blocks vasoconstrictor and aldosterone-secreting effects of angiotensin II
- Selective blocking of AT1 receptor
Dosage and Administration
- Titration of components for individual patients
- Initial therapy with 5/20 mg once daily
- Maximum dosage of 10/40 mg once daily
Interaction
- Potential attenuation by NSAIDs including selective COX-2 inhibitors
- Monitoring of blood pressure, renal function, and electrolytes
Contraindications
- Incompatibility with co-administration of Aliskiren in patients with diabetes
Side Effects
- Peripheral edema
- Headache
- Flushing
- Dizziness
- Sprue-like enteropathy
Pregnancy and Lactation
- Pregnancy Category D
- Avoidance in 2nd and 3rd trimester
- Potential fetal death
- Discontinuation during pregnancy or nursing if adverse effects are observed
Precautions and Warnings
- Caution in volume- or salt-depleted patients
- Risk in patients with severe aortic stenosis or obstructive coronary artery disease
Use in Special Populations
- Lack of established safety and effectiveness in pediatric patients
- No overall differences observed between subjects 65 years or older and younger subjects
- No studies in patients with renal impairment
- Initial therapy not recommended in hepatically impaired patients
Overdose Effects
- No information available on humans
Therapeutic Class
- Combined antihypertensive preparations
Storage Conditions
- Do not store above 30°C
- Keep away from light
- Keep out of the reach of children